A phase I, single-center, open-label, dose-escalation study (University of Alabama [UAB] 9614) has been undertaken to evaluate the feasibility and safety of uracil and tegafur (in a molar ratio of 4:1 [UFT]) plus oral
Sharon Spencer, MD
Advertisement
Articles by Sharon Spencer, MD
Advertisement
Latest Updated Articles
- UFT/Oral Calcium Folinate Plus Radiation in Pancreatic Cancer
Published: July 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
3
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
4
Taking Stock of Immune Effector Cell Therapy Developments in GI Cancers
5
